Evidence map›Paper›PMID 35991757›Full record

ArticleACS sustainable chemistry & engineering2022

Robert Hartmann, Marco Beaumont, Eva Pasquie, Thomas Rosenau, Rodrigo Serna-Guerrero

Open access · hybridAbstract read
In one paragraph

Article in ACS sustainable chemistry & engineering, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
1.4field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 20 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 4 countries.

Robert HartmannDepartment of Chemical and Metallurgical Engineering, School of Chemical Engineering, Aalto University, P.O. Box 12200, FIN-00076 Espoo, Finland.ORCID https://orcid.org/0000-0001-9126-8528
Marco BeaumontDepartment of Chemistry, Institute for Chemistry of Renewable Resources, University of Natural Resources and Life Science, A-3430 Tulln, Austria.ORCID https://orcid.org/0000-0002-2571-497X
Eva PasquieDepartment of Bioproducts and Biosystems, School of Chemical Engineering, Aalto University, FIN-00076 Espoo, Finland.
Thomas RosenauDepartment of Chemistry, Institute for Chemistry of Renewable Resources, University of Natural Resources and Life Science, A-3430 Tulln, Austria.ORCID https://orcid.org/0000-0002-6636-9260
Rodrigo Serna-GuerreroDepartment of Chemical and Metallurgical Engineering, School of Chemical Engineering, Aalto University, P.O. Box 12200, FIN-00076 Espoo, Finland.
BOKU University · ATAalto University · FIFraunhofer Center for Chemical-Biotechnological Processes · DEInstitut polytechnique de Grenoble · FR

Funding

Austrian Science Fund FWF J 4356
6 · The paper itself

Abstract

The majority of reagents currently used in mineral flotation processes are fossil-based and potentially harmful to the environment. Therefore, it is necessary to find environmentally-friendly alternatives to reduce the impact of mineral processing activities. Chitin nanocrystals are a renewable resource that, due to the natural presence of amino groups on its surface, represents a promising collector for various minerals of economic relevance. This study examines the one-pot functionalization of chitin nanocrystals with aldehyde structures to obtain hydrophobized colloids suitable for mineral flotation. The chemical properties of these nano-colloids were investigated by nuclear magnetic resonance spectroscopy, their colloidal behavior and structure by electrophoretic light scattering and atomic force microscopy, and their wettability through water contact angle measurements. The functionalized

Identifiers

PMID35991757
PMCPMC9382668
OpenAlexW4289794096

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.